
Most CA Nursing Homes Below Full COVID Vaccine Compliance
The majority of nursing homes in California have not reached full compliance with a statewide COVID-19 vaccine mandate for staff at long-term care facilities, and
The majority of nursing homes in California have not reached full compliance with a statewide COVID-19 vaccine mandate for staff at long-term care facilities, and
An experimental drug, NAP, has been found to remedy slow development, poor communication and brain issues similar to those found in Alzheimer’s patients. Find out
BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic
BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so
DIAGNOSIS: The PrecivityAD™ blood test accurately and reliably detected brain amyloid on a single blood sample. Intended for people with memory and thinking issues, the
WEBINAR: You are cordially invited to a conversation with Dr. David Holtzman about his PrecivityAD groundbreaking new blood test to aid in the diagnosis of
TEEPA VIDEO: How do I stay protected from Coronavirus, when caring for a physically healthy person with dementia? Physical contact is unavoidable — forget 6
THE CORONA VIRUS: Around the world, dementia researchers are studying SARS-CoV-2 virus’ (the cause of COVID-19) long-term effects on the brain and nervous system. It
ALZFORUM: Last year, people with dementia were most vulnerable, and this constrained research. Investigators adjusted and managed to make strides in important areas, from plasma
DIAGNOSIS: Worried about minor memory changes? The British Medical Journal revealed how unnecessary tests led to a 23% over-diagnosis rate. Learn the risks, harms &
Empower yourself with a detailed report of your brain’s function, consisting of an assessment of your cognitive function and your brain connectivity with a quick 45-minute on-site appointment.
Kimberly Warnick, Certified Dementia Practitioner and Care Navigator
Selling Alzheimer’s books takes time – buyers rarely commit right away. Smart authors plan for the long game, offering gentle, repeated reminders to buy. No tool does this more effectively or simply than the Alzheimer’s & Dementia Weekly Newsletter service. Keep your book—and its message—at the center of your readers’ attention.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.